Anzeige
Mehr »
Samstag, 14.06.2025 - Börsentäglich über 12.000 News
Anleger aufgepasst: Weltbank setzt jetzt ein neues Signal für Investoren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Marketwired
94 Leser
Artikel bewerten:
(0)

Technology from Canada's Most Famous Robot, Canadarm, to Help Doctors Care for Children / Children undergoing surgery willget help from robotic arm technology used on the International Space Station

TORONTO, ONTARIO -- (Marketwired) -- 03/09/15 -- Canadarm, the robot that established Canada's proud international reputation for robotics innovation, has inspired several generations of scientists and engineers to develop new technologies for industry, medicine, and other applications.

Today, Industry Minister James Moore visited The Hospital for Sick Children (SickKids) in Toronto to witness first-hand how Canada's investment in space science research and development will be used to help drive improvements to surgical care for children.

KidsArm, a descendant of Canadarm, is the first image-guided robotic surgical arm in the world, specifically designed for surgery for children. KidsArm is a medical tool that will enable surgeons to safely and rapidly perform minimally invasive surgical procedures on children. It is capable of working in small and delicate spaces and will offer enhanced dexterity and precision.

The KidsArm robotic arm system was developed using technology built for Dextre and Canadarm2. It is the result of collaboration between SickKids' Centre for Image Guided Innovation and Therapeutic Intervention (CIGITI) and private-sector partners including MacDonald, Dettwiler and Associates Ltd. (MDA), the Canadian company that built these Canadian world-renowned space robots. Other partners include Philips and other companies.

In 2010, SickKids received $10 million from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) to support the development of KidsArm, MR-guided interventions including Focused Ultrasound and Virtual and Physical Surgical Simulation. Over the past five years, the CIGITI team has been hard at work in the research lab, building on the original KidsArm design. They are currently developing next-generation KidsArm robot prototypes, which will be ready for clinical use within the next three to five years.

Minister Moore took this opportunity to congratulate Dr. James Drake, Director of CIGITI and Head of Neurosurgery at SickKids, and the CIGITI team on the KidsArm robotic surgical system.

Quick facts

--  KidsArm is funded by the Government of Canada.

--  The next-generation KidsArm robots are being developed for use in
    neurosurgery, craniofacial surgery, urological surgery, general surgery
    and fetal surgery.

--  These surgical robots will be capable of working in small and delicate,
    difficult-to-reach spaces under supervised image guidance.

    These robots will enable surgeons to quickly navigate to a treatment
    region, avoid fragile structures such as blood vessels, and rapidly
    perform procedures such as cutting, applying suction, using a laser, and
    suturing vessels and tissues.


--  The KidsArm project is an initiative of CIGITI, a research program that
    brings together surgeons, radiologists, software developers and
    engineers to develop innovative technologies in robotic and minimally-
    invasive surgery.

--  The Government of Canada's support for the research and development
    behind KidsArm is aligned with Canada's Space Policy Framework's core
    principle of supporting excellence in key technological capabilities, in
    this case robotics.


Quotes

"Canadians are incredibly proud of our achievements in space robotics such as Canadarm and Dextre. Soon, taxpayer-funded technology used in Canada's most famous robot will help improve health outcomes for children here in Canada and around the world. KidsArm demonstrates how innovation in space robotics can lead to innovation in health research. Canadian families will soon reap direct health benefits from Canada's proud history in space."

- Industry Minister James Moore

"Today, we are proud to introduce Industry Minister James Moore to the KidsArm project. The research we are doing in the CIGITI lab has progressed at an exciting rate, and through our prototype testing, we are getting closer to bringing this advanced technology to the forefront of surgical care for children."

- Dr. James Drake, Director of CIGITI and Head of Neurosurgery at SickKids

Associated Links

Biography: Dr. James Drake

Web story by SickKids (2010)

Web story by SickKids (2014)

News release by FedDev (2010)

Canadian Space Technology to Help Sick Children

Follow us on Social Media!

Contacts:
Canadian Space Agency
Media Relations Office
450-926-4370
Twitter: @csa_asc
www.asc-csa.gc.ca

© 2015 Marketwired
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.